Navigation Links
Ruediger Naumann-Etienne Appointed to IRIDEX Board of Directors
Date:12/18/2009

MOUNTAIN VIEW, Calif., Dec. 18 /PRNewswire-FirstCall/ -- IRIDEX Corporation (Nasdaq: IRIX) announced today the appointment of Ruediger Naumann-Etienne to its Board of Directors.

"Rudi brings to our Board 25 years of experience in growing medical device companies," said Theodore A. Boutacoff, President and CEO of IRIDEX, "beginning in the investment banking field with Hambrecht & Quist followed by CEO/President positions with Diasonics, OEC Medical Systems and Quinton Cardiology Systems. Rudi has also made contributions on a number of public company boards including Bio-Rad Laboratories (BIO), Varian Medical Systems (VAR), Encision (ECIA) and Laserscope (LSCP). We believe his medical device industry and operational experience will be valuable to IRIDEX and look forward to his contributions."

Dr. Naumann-Etienne, 63, has been the owner and Managing Director of Intertec Group, an investment company specializing in the medical device field, since 1989. He has been the Chairman of Cardiac Science (CSCX) since 2006. From 2000 to 2005, Dr. Naumann-Etienne served as Chairman of Quinton Cardiology Systems, one of the predecessor companies of Cardiac Science. From 2000 to 2003, he also served as Chief Executive Officer of this company. From 1993 until 1999, Dr. Naumann-Etienne was Chairman of OEC Medical Systems, a manufacturer of fluoroscopic imaging systems and from 1987 to 1990 he was President and Chief Operating Officer of Diasonics, a manufacturer of diagnostic imaging equipment. Dr. Naumann-Etienne is also currently a director of Varian Medical Systems and Encision Inc.

"I have been following IRIDEX for many years and am looking forward to working with the Board and Management to support the Company's growth plans," commented Dr. Naumann-Etienne.

Dr. Naumann-Etienne holds a Ph.D. in International Finance from the University of Michigan. He received a Master's Degree in Industrial Management from the Georgia Institute of Technology and did his undergraduate studies in Business Administration at the Technical University Berlin, Germany.

About IRIDEX

IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems and delivery devices. We provide solutions for multiple specialties, including ophthalmology, dermatology and otolaryngology. We maintain a deep commitment to the success of our customers, with comprehensive technical, clinical, and service support programs. IRIDEX is dedicated to a standard of excellence, offering superior technology for superior results. IRIDEX products are sold in the United States through a direct sales force and internationally through a combination of a direct sales force and a network of approximately 100 independent distributors into 107 countries. For further information, visit the Company's website at http://www.iridex.com.

Safe Harbor Statement

This announcement contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Act of 1934, as amended, relating to the contributions and benefits IRIDEX may receive as a result of Dr. Naumann-Etienne becoming a member of IRIDEX' Board of Directors. Please see a detailed description of certain other risks relating to IRIDEX contained in our Quarterly Reports on Form 10-Q and Annual Report on Form 10-K for the fiscal year ended January 3, 2009 filed with the Securities and Exchange Commission. Forward-looking statements contained in this announcement are made as of this date and will not be updated.

SOURCE IRIDEX Corporation


'/>"/>
SOURCE IRIDEX Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger
2. Autism Spectrum Therapies Co-Founder and Chief Clinical Officer Dr. William Frea Appointed to Board of Directors of Los Angeles Chapter of Autism Speaks
3. David Feldman, M.D. Appointed Co-Principal Investigator of DuraHeart(TM) Left Ventricular Assist System U.S. Clinical Trial
4. IRIDEX Introduces IQ 532 Dual Port Green Laser System at the American Academy of Ophthalmology
5. IRIDEX Introduces Modular Multi-Wavelength Laser Solution at the American Academy of Ophthalmology
6. IRIDEX Introduces New ENT Laser Delivery Devices at AAO-HNSF Annual Meeting
7. Instacare Corp. Board of Directors Sets Growth Plans for 2010
8. Boston Scientific Announces Election of Nelda Connors to Its Board of Directors
9. In Preparation for Commercialization of SVARA(TM), TechniScan Appoints Joe Pepper, PhD to Board of Directors
10. Oxygen Biotherapeutics, Inc. Expands Board of Directors
11. Liberator Medical Strengthens its Board of Directors with the Addition of Mr. Joseph Farish and Mr. Robert S. Cuillo
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... 2017 The Rebound mobile app is poised to ... the tide of prescription drug addiction. The app empowers users ... and stepping down their dosage in a safe, controlled manner ... 2017; the first 100,000 people to sign up will enjoy ... ...
(Date:9/27/2017)... NEW YORK , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: ... data solutions, today announced that its MyDario product is expected to appear ... listings for when The Dr. Oz Show airs in your area: ... The nine-time Emmy award-winning, The ... ...
(Date:9/22/2017)... 2017  As the latest Obamacare repeal effort moves ... (R-LA) and Lindsey Graham (R-SC) medical ... device industry is in an odd place.  The industry ... excise tax on medical device sales passed along with ... patients, increased visits and hospital customers with the funding ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Dickinson Insurance and ... and financial preparation services, is providing an update on a charitable event that ... City Rescue is a locally recognized nonprofit that provides shelter and care for ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... The American ... to become its next President and Chief Executive Officer, succeeding Dr. James C. Puffer ... Elect beginning July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... PharmD ‘17, and Jennifer Huggins, PharmD ’17, along with clinical associate professor ... prevention of cardiovascular diseases during the 15th Annual Women’s Health Conference. The ...
(Date:10/13/2017)... ... , ... Many families have long-term insurance that covers care for a family ... for care if the client has a cognitive impairment diagnosis. , “What this ... often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, owner ...
(Date:10/13/2017)... ... ... Global Healthcare Management’s 4th Annual Kids Fun Run brought out many kids ... sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at getting kids excited ... all ages; it is a non-competitive, non-timed event, which is all about having fun ...
Breaking Medicine News(10 mins):